Clinical trial
SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue…
NCT00005862 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00005862 |
|---|---|
| Title | SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas |
| Official title | A Phase II Trial of SU5416 (NSC #696819) in Previously Treated Patients With Advanced, Metastatic and/or Locally Recurrent Soft Tissue Sarcomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Stromal Tumor, Sarcoma |
| Intervention type | Drug |
| Interventions | semaxanib |
| Enrollment | 60 |
| Start date | Oct 1, 2000 |
| Primary completion | Jul 1, 2004 |
| First posted | Feb 12, 2004 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: